Can I invest in SIP and Lumpsum in UTI-Healthcare Fund - Direct (G) Direct Growth?

Yes, you can invest both lumpsum and SIP in UTI-Healthcare Fund - Direct (G). Minimum lumpsum investment UTI-Healthcare Fund - Direct (G) is ₹5,000 and minimum SIP amount is ₹500 . Lumpsum option is ideal for investors with higher investible corpus and market experience. SIP option is recommended for retail investors who do not have the time or expertise to time the market.

What is the NAV of UTI-Healthcare Fund - Direct (G) Direct Growth?

The latest NAV (Net Asset Value) of UTI-Healthcare Fund - Direct (G) is UTI-Healthcare Fund - Direct (G) is ₹331.14 as on 2025-01-02.

Which are the biggest stock holdings of UTI-Healthcare Fund - Direct (G)?

The 5 biggest stock holdings of UTI-Healthcare Fund - Direct (G) are: Sun Pharma.Inds. (10.73%), Cipla (5.75%), Ajanta Pharma (4.85%), Dr Reddy's Labs (4.70%), Glenmark Pharma. (3.93%)

What are the top sectors UTI-Healthcare Fund - Direct (G) invests in?

A majority of UTI-Healthcare Fund - Direct (G) 's AUM worth ₹1,203.23 (Cr) is invested in these 3 top sectors: Pharmaceuticals & Biotech : 75.33% Healthcare Services : 21.22% Cash & Others : 1.41%

Mutual Funds
UTI-Healthcare Fund - Direct (G)

UTI-Healthcare Fund - Direct (G)

Sectoral / Thematic

Invest Now

NAV
331.14(0.51%)
Fund Size (CR)
₹1,203.23
Expense Ratio
1.25
Scheme Type
Active Fund
Value Research

Min. investment
₹5,000
Minimum Additional Investment
₹1,000
Minimum SIP Investment
₹500
Minimum Withdrawal
₹0
Exit Load
1% of applicable Net Asset Value - If the amount sought to be redeemed or switch out is invested for a period of up to 3 months from the date of allotment Nil - If the amount, sought to be redeemed or switch out is invested for a period of more than 3 months from the date of allotment
1%
Return Since Launch
17.46%

Absolute Return: 2.57%

Annualized Return: 0%

Basic Details

Scheme Manager

Kamal Gada

Bench Mark

BSE Healthcare TRI

Type

OPEN

Lumpsum Returns

Period Invested For	₹10,000 Invested on	Latest Value	Absolute Returns	Annualised Returns	Category Avg	Rank within Category
1 Week	24 December 2024	10252.69	2.53%	-	0.63%	46/816
1 Month	29 November 2024	10223.75	2.24%	-	-0.22%	107/784
3 Month	1 October 2024	10124.80	1.25%	-	-5.41%	95/757
6 Month	1 July 2024	12464.45	24.64%	-	2.29%	18/713
1 Year	1 January 2024	14358.49	43.58%	43.58%	22.96%	22/628
3 Year	31 December 2021	17896.22	78.96%	21.41%	18.68%	157/480
5 Year	1 January 2020	36191.15	261.91%	29.34%	22.18%	69/388
Since Inception	1 January 2013	69081.00	590.81%	17.46%	17.07%	370/823

Note: Lumpsum Returns since Inception Date.

SIP Returns

Period Invested For	₹10,000 Invested on	Investments	Latest Value	Absolute Returns	Annualised Returns
1 Year	1 February 2024	1,20,000	142120.77	18.43%	18.43%
3 Year	3 January 2022	3,70,000	617791.37	66.97%	18.64%
5 Year	3 February 2020	6,00,000	1178939.13	96.49%	14.46%
10 Year	2 February 2015	12,00,000	3354439.90	179.54%	10.83%

Note: SIP Returns since Inception Date.

Tax Treatment

If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 10%, if your total long term capital gain exceeds 1 lakh. Any cess/surcharge is not included.If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 15%. Any cess/surcharge is not included in the 15%.

Mutual Funds Calculator

Investment type
Scheme based

SIP
Lumpsum

Monthly Investment (₹)

Expected Returns Rate (%)

Time Period (in Years)

Start your SIP now

Invested Amount
₹25,000
Estimated Returns
₹19,059

76%

Returns

Future value of your investment

₹44,059

Risk Ratios

4.53%

Standard Deviation

0.82%

Beta

0.92%

Sharpe Ratio

0.31%

Treynor's Ratio

10.20%

Jension's Alpha

Asset Allocation

Sector Allocation

Top 10 stock holding in portfolio

Stock Invested in	% of Total Holdings	Quantity	Value (Cr)	Asset Type	Segment
Sun Pharma.Inds.	10.73%	725000	129.12	Equity	Pharmaceuticals
Cipla	5.75%	450660	69.13	Equity	Pharmaceuticals
Ajanta Pharma	4.85%	193047	58.35	Equity	Pharmaceuticals
Dr Reddy's Labs	4.70%	470234	56.54	Equity	Pharmaceuticals
Glenmark Pharma.	3.93%	309311	47.28	Equity	Pharmaceuticals
Gland Pharma	3.85%	266306	46.28	Equity	Pharmaceuticals
Apollo Hospitals	3.41%	60000	40.97	Equity	Healthcare
Fortis Health.	3.35%	611658	40.32	Equity	Healthcare
P & G Health Ltd	3.18%	74000	38.31	Equity	Pharmaceuticals
Divi's Lab.	3.15%	61480	37.95	Equity	Pharmaceuticals

Peer Comparison

Scheme Name	Asset Size (Cr)	1M	3M	6M	1Y	3Y
UTI-Healthcare Fund - Direct (G)	1203.23	2.24%	1.25%	24.64%	43.58%	21.41%
HDFC Pharma and Healthcare Fund - Direct (G)	1459.59	3.89%	6.11%	29.92%	52.37%	-
HDFC Pharma and Healthcare Fund - Direct (IDCW)	1459.59	3.89%	6.11%	29.92%	52.37%	-
LIC MF Infrastructure Fund - Direct (G)	852.07	1.46%	-0.68%	2.96%	49.86%	33.99%
LIC MF Infrastructure Fund - Direct (IDCW)	852.07	1.46%	-0.68%	2.95%	49.81%	33.83%
ICICI Pru P.H.D Fund - Direct (G)	5044.63	4.68%	3.30%	24.91%	49.21%	25.43%

News

UTI Conservative Hybrid Fund announces Income Distribution cum capital withdrawal (IDCW)
UTI Mutual Fund has announced IDCW is 01 January 2025 as the record date for declaration of Income Distribution cum capital withdrawal (IDCW) under Regular Plan-Monthly IDCW Option and Direct Plan-Monthly IDCW Option of UTI Conservative Hybrid Fund. The quantum of IDCW will be Rs 0.0800 per unit or 0.80% on the face value of Rs 10 per unit.
Powered by Capital Market - Live News

UTI MF announces change in benchmark index under its schemes

UTI Mutual Fund has announced change in the benchmark of UTI Annual Interval Fund ' I with effect from November 29, 2024

Changes in Benchmark Index:

Scheme Name	Existing Tier I Benchmark as per PRC Matrix	Revised Tier I Benchmark as per PRC Matrix
UTI Annual Interval Fund ' I	CRISIL Low Duration Debt Index	CRISIL Low Duration Debt A-I Index
UTI Annual Interval Fund - II	CRISIL Low Duration Debt Index	CRISIL Low Duration Debt A-I Index
UTI Fixed Term Income Fund Series XXXVI - I (1574 Days)	CRISIL Medium to Long Term Debt Index	CRISIL Short Duration Debt A-II Index

Powered by Capital Market - Live News

UTI Conservative Hybrid Fund announces Income Distribution cum capital withdrawal (IDCW)
UTI Mutual Fund has announced IDCW is 02 December 2024 as the record date for declaration of Income Distribution cum capital withdrawal (IDCW) under Regular Plan-Monthly IDCW Option and Direct Plan-Monthly IDCW Option of UTI Conservative Hybrid Fund. The quantum of IDCW will be Rs 0.0800 per unit or 0.80% on the face value of Rs 10 per unit.
Powered by Capital Market - Live News

Fund House Details & Investment Objective

Date of Incorporation

1 January 2013

Total AUM (Cr)

₹1203.23

UTI-Healthcare Fund - Direct (G) is an Sectoral / Thematic-oriented fund from the renowned AMC, UTI Mutual Fund. Launched in 1 January 2013, this fund is managed by Kamal Gada. With assets under management (AUM) worth ₹1,203.23 (Cr), as of 2 January 2025, UTI-Healthcare Fund - Direct (G) is categorized as a Sectoral / Thematic within its segment. The fund has generated a return of 17.46% since its launch.
The current NAV of UTI-Healthcare Fund - Direct (G) is ₹331.14, as on 2 January 2025. The fund's benchmark index is BSE Healthcare TRI. You can invest in UTI-Healthcare Fund - Direct (G) via both lumpsum and SIP modes. The minimum SIP amount in the fund is ₹500 while the minimum lumpsum investment is ₹5,000.

Being an open-ended fund, you can exit the fund anytime subject to applicable exit loads:
1.00% - If redeemed / switched out less than one year from the date of allotment. Nil - If redeemed / switched out greater than or equal to one year from the date of allotment. The fund has generated 21.41% and 29.34% CAGR in the last 3 and 5 years respectively.

The fund aims to provide long-term capital appreciation and growth, by investing in a mix of financial instruments 97.87% in Equity, 0.11% in Debt and 2.01% in cash and cash equivalents.
The top 5 sectors the fund invests in are: 75.33% in Pharmaceuticals & Biotech, 21.22% in Healthcare Services, 1.41% in Cash & Others, 1.04% in Insurance, 0.85% in Healthcare Equipment & Su

FAQs

How to Invest in UTI-Healthcare Fund - Direct (G) Direct Growth?

UTI-Healthcare Fund - Direct (G) is a popular fund in the Sectoral / Thematic segment. The fund has generated a return of 17.46% since inception. Looking to invest in UTI-Healthcare Fund - Direct (G) How about earning 1% extra return? All this is possible with m.Stock! Investing in UTI-Healthcare Fund - Direct (G) is super easy and convenient with m.Stock. Here’s how you can begin:

Login to your m.Stock account. If you do not have an account, open m.Stock Demat account and enjoy 1% extra returns plus Zero Brokerage across products for life.
In the ‘Menu’ section, under ‘Products’, select ‘Mutual Funds’ .
In the search bar, enter the fund name, in this case, UTI-Healthcare Fund - Direct (G)
On the top right corner you’ll see two options – Lumpsum and SIP. You can choose either based on your risk appetite and available investible corpus.
If you choose to invest a Lumpsum: Enter amount, select payment mode (UPI or Netbanking), and click on ‘invest a lumpsum’. Make the payment and your lumpsum investment is complete.
If you choose the SIP route, then enter SIP amount, SIP date, and set up ‘Autopay’ facility.

So, why wait? Invest in UTI-Healthcare Fund - Direct (G) today and reap the benefits of this Sectoral / Thematic fund!

How much returns has UTI-Healthcare Fund - Direct (G) Direct Growth generated?

In the short term, i.e., 1 year, UTI-Healthcare Fund - Direct (G) has generated annualised return of 43.58%. In the long-term, the fund has generated 21.41% and 29.34% in 3 and 5 years respectively. Since its inception, the fund has generated 17.46% returns.

What is the expense ratio of UTI-Healthcare Fund - Direct (G) Direct Growth?

The expense ratio of UTI-Healthcare Fund - Direct (G) Direct Growth is 1.25%. Expense ratio is the fees payable by investors of the scheme towards management, research and overall upkeep of the fund. The higher the expense ratio, the lower is the in-hand return for the investor. Expense ratio for direct plans is lower than regular plans, making them ideal for investors.

What is the AUM of UTI-Healthcare Fund - Direct (G) Fund Direct Growth?

The Assets Under Management (AUM) of UTI-Healthcare Fund - Direct (G) is ₹1,203.23 (Cr) as of 2025-01-02 AUM shows the fund’s popularity and is often indicative of fund strength.

How to redeem or withdraw money from UTI-Healthcare Fund - Direct (G) Direct Growth?

Redeeming or selling units of UTI-Healthcare Fund - Direct (G) is relatively simple. But before you redeem, ensure that the fund has completed the minimum lock-in period else you will be charged an exit load.

To redeem from UTI-Healthcare Fund - Direct (G):

Login to your m.Stock account
In portfolio, your mutual fund investments will be visible under ‘MF’
Select the fund you wish to redeem from (in this case UTI-Healthcare Fund - Direct (G)).
Click on ‘Redeem’ button
You have 2 options – redeem by units and redeem by value (you can only redeem free units)
Select units to be redeemed and click on submit.
Redemption value will be credited to your account in 2-3 working days (as per timelines set by SEBI).